E015: Mike Romanos: Building the Future of Biotech Spinouts

In 2022, it was estimated that up to 90% of startups failed within the first 5 years of forming. Against these odds, Dr. Mike Romanos successfully built 3 world-class biotech spinouts. After raising a Series C in his previous startup and 35 years in industry, Mike has joined Imperial as Associate Dean for Enterprise in the Faculty of Medicine. In his role at Imperial as well as at LifeArc, Mike aims to make spinning out more accessible enabling more academics to build world-class biotech companies. #biotechnology #ceo #podcast #healthtechFollow: Twitter: https://twitter.com/livialifes Linkedin: www.linkedin.com/in/livialifes About Me: Neuroute - copilot for clinical trials https://www.neuroute.co